Showing results (91-100 of 281) with videos related to

Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|January 18, 2006
Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolitesJörn Lötsch, Carsten Skarke, Helmut Schmidt, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 productionCarsten Skarke, Maximilian Reus, Ronald Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Developmental expression of functional cyclooxygenases in zebrafishTilo Grosser, Shamila Yusuff, Ellina Cheskis, et al.
European Journal of Pharmacology|April 21, 2009
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceUlf Siemoneit, Carlo Pergola, Bianca Jazzar, et al.
Anesthesiology|October 3, 2002
Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?Jörn Lötsch, Michael Zimmermann, Jutta Darimont, et al.
Scientific Reports|December 8, 2017
A Pilot Characterization of the Human ChronobiomeCarsten Skarke, Nicholas F Lahens, Seth D Rhoades, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthmaZeina Jaffar, Maria E Ferrini, Mary C Buford, et al.
Methods in Enzymology|October 24, 2007
Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS methodWen-Liang Song, John A Lawson, Miao Wang, et al.
Journal of Lipid Research|September 1, 2006
Oxidized derivatives of omega-3 fatty acids: identification of IPF3 alpha-VI in human urineJohn A Lawson, Seongjin Kim, William S Powell, et al.
Pageof 29